Abstract Deadline is June 18

The 15th Biennial Ovarian Cancer Research Symposium, co-presented by the Rivkin Center and the American Association for Cancer Research, will be held on September 20-21, 2024 in Seattle, WA.

Keynote Speakers:

Jose Conejo-Garcia, MD, PhD | Duke University School of Medicine

Kathleen Moore, MD, MS | Stephenson Cancer Center

Continuing Medical Education Activity AMA PRA Category 1 Credits™ available.

ABSTRACT SUBMISSION

We are accepting research and clinical abstracts in all fields of ovarian cancer research to be considered for oral or poster presentation. Abstract categories include:

Biology of Ovarian Cancer

Prevention, Early Detection, & Interception

Emerging Therapeutics

Novel Immunotherapies

Health & Healthcare Disparities

Survivorship

Patient Advocacy

Abstracts are due on June 18, 2024 at 5 pm Pacific Time. To learn about submission guidelines, please visit the Abstracts tab of the symposium website.

TRAVEL AWARDS

The Rivkin Center is offering $500 Travel Scholarships to support graduate students and postdocs who submit an abstract and who would otherwise be unable to attend the Symposium. Special consideration will be given to those from underrepresented or underserved backgrounds and regions.

Learn how to apply by visiting the Travel Awards tab. The deadline is the same as the abstract submission deadline: June 18, 2024.

REGISTRATION

Early registration ends on August 5, 2024. The 2024 Symposium is fully live; no virtual or recorded components will be available. All meals will be provided to registrants. Learn more by visiting the Registration tab.

ACCOMODATIONS

The Symposium will be held at the Seattle Airport Marriott. We have arranged a discounted group rate for hotel rooms. The group rate is available, while supplies last, until August 29, 2024.

We look forward to welcoming you to Seattle in September!

Sincerely,

Symposia Co-chairs

Joyce Liu, MD, MPH

Nita Maihle, PhD

Brad Nelson, PhD

Dmitriy Zamarin, MD, PhD

THANK YOU TO OUR SPONSORS

ImmunoGen

Andy Hill CARE Fund

Merck

Knight Cancer Institute